Himalaya Nutravedics India IPO 2026: Price Band, GMP, Dates, Lot Size, Allotment & Listing Details

By /
Himalaya Nutravedics India Limited IPO
HN
Himalaya Nutravedics India Limited IPO
Ayurvedic & Nutraceutical Formulations · Capsules, Tablets & Medicated Oils · Hyderabad, Telangana
📋 BSE SME IPO Fresh Issue BSE SME
₹106
Upper Price
₹26.50 Cr
Issue Size
Sep 29, 2026
Listing Date
₹66.85 Cr
Market Cap (Pre)
📅 IPO Timetable
All dates tentative
🟢
IPO Opens
Tuesday, 22 September 2026
Bidding starts — apply before close
🔒
IPO Closes
Thursday, 24 September 2026
Last day to bid — closes at 5:00 PM IST
📊
Basis of Allotment
Friday, 25 September 2026
Allotment finalised by registrar
🔄
Refund & Share Credit
Monday, 28 September 2026
Unallotted funds returned; shares credited to demat
🏷️
Tuesday, 29 September 2026
Trading begins from 10:00 AM IST
📋 IPO Details
IPO Open Date22 September 2026 (Tue)
IPO Close Date24 September 2026 (Thu)
Listing Date29 September 2026 (Tue)
Face Value₹10 per share
Price Band₹100 to ₹106
Issue Price (Upper Band)₹106 per share
Issue TypeBookbuilding IPO
Lot Size1,200 shares
Total Issue Size24,99,600 shares (₹26.50 Cr)
Fresh Issue24,99,600 shares (₹26.50 Cr)
Offer for Sale (OFS)Nil
Pre-Issue Shares63,06,720
Post-Issue Shares88,06,320
Promoter Holding (Pre)95.14%
Market Cap (Pre-IPO)₹66.85 Cr
Listing ExchangeBSE SME
Lead ManagerNirbhay Capital Services Pvt.Ltd.
RegistrarKfin Technologies Ltd.
💰 Lot Size & Minimum Investment
At upper price ₹106
Investor TypeLotsSharesAmount
Individual (Retail) — Min22,400₹2,54,400
Individual (Retail) — Max22,400₹2,54,400
S-HNI (sNII) — Min33,600₹3,81,600
S-HNI (sNII) — Max78,400₹8,90,400
B-HNI (bNII) — Min89,600₹10,17,600
⚠️ Note: Investors can bid for a minimum of 2,400 shares (2 lots) and in multiples of 1,200 shares thereafter.
👥 Investor Reservation
Allocated portion of Net Offer
Not more than 50%
QIB Portion
Not less than 35%
Retail Portion
Not less than 15%
NII Portion
📊 Subscription Status
Loading…
📈 Company Financials
Restated Consolidated · ₹ Crore
Metric31 Mar 202631 Mar 202531 Mar 2024
Total Assets24.4210.826.09
Total Income43.1221.0014.43
PAT7.392.230.43
EBITDA8.102.990.94
Net Worth16.386.751.34
Reserves & Surplus10.072.760.53
Total Borrowing5.131.763.24
Income Trend
FY 2023–24₹14.43 Cr
FY 2024–25₹21.00 Cr
FY 2025–26₹43.12 Cr
🎯 Key Performance Indicators
63.87%
ROE
Mar 31, 2026
0.31
Debt/Equity
Mar 31, 2026
36.41%
ROCE
Mar 31, 2026
17.16%
PAT Margin
Mar 31, 2026
18.82%
EBITDA Margin
Mar 31, 2026
45.12%
RoNW
Mar 31, 2026
3.97x
Price/Book
Mar 31, 2026
26.70
NAV
Mar 31, 2026
⚖️ Valuation & EPS
Pre-IPO EPS
₹11.72
Based on pre-issue shares
P/E: 9.04x
Post-IPO EPS
₹8.39
Based on post-issue shares
P/E: 12.63x
Price to Book Value
3.97x
At upper price band ₹106
Market Cap (Pre-IPO)
₹66.85 Cr
At issue price ₹106
ℹ️ Pre-IPO EPS (₹11.72) is based on pre-issue shares (63,06,720) and applicable earnings. Post-IPO EPS (₹8.39) accounts for the dilution resulting from the issuance of 24,99,600 fresh equity shares extending the total post-issue equity to 88,06,320 shares. Post-IPO Market Cap expands to ₹93.35 Cr at the upper issue price of ₹106.
🎯 Objects of the Issue
Net proceeds utilisation
1
Funding Working Capital Requirements
₹13.75 Cr
2
Business Development and Digital Marketing Activities
₹7.50 Cr
3
General Corporate Purposes
Balance
Total Net Proceeds Goal ₹21.25 Cr
🏢 About Himalaya Nutravedics India Ltd.
Est. 2022 · Hyderabad, Telangana · Ayurvedic & Nutraceutical Formulations

Himalaya Nutravedics India Limited, incorporated in June 2022, is a Hyderabad-based Ayurvedic and nutraceutical manufacturing enterprise. The company is actively engaged in the formulation, manufacturing, and marketing of a wide array of premium wellness solutions, including Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders catering across therapeutic segments such as digestive health, immunity, metabolic health, and pain management.

The business markets its branded product portfolio primarily through healthcare practitioners and also undertakes specialized third-party contract manufacturing. Headquartered in Hyderabad, the company has expanded its market reach across 17 states and one union territory in India. Its manufacturing unit located in Hyderabad, Telangana, holds prestigious certifications including ISO 22000:2018, ISO 9001:2015, and WHO-GMP. As of April 30, 2026, the company employed a skilled workforce of 80 personnel.

Brand Ecosystem
💊
Ayurvedic Formulations
Specialized Softgel and Hardgel capsules, tablets, and medicated therapeutic oils.
🌿
Nutraceuticals & Immunity
Targeted products for metabolic, digestive, immunity support, and protein powders.
🏭
WHO-GMP Certified Plant
Hyderabad manufacturing hub certified under ISO 22000:2018, ISO 9001:2015, and WHO-GMP.
🩺
Healthcare Network
Prescription-driven marketing through healthcare practitioners spanning across 17 Indian states.
Competitive Strengths
🏆Integrated multi-dosage manufacturing capability across diverse delivery forms.
⚙️Strong doctor acceptance supported by verifiable product efficacy and clinical performance.
📋Long-standing, collaborative relationships with raw material suppliers and contract clients.
📈Rapid geographic expansion across 17 states and one union territory within a concise operational history.
Company Promoters
RA
Rohit Asawa & Divya Asawa
Promoters, Himalaya Nutravedics India Ltd.
CA
Chanda Asawa & Rama Raju Penmatsas
Promoters, Himalaya Nutravedics India Ltd.
📅 Key Dates
IPO Opens22 Sep 2026
IPO Closes24 Sep 2026
Allotment25 Sep 2026
Refund & Share Credit28 Sep 2026
Listing Day29 Sep 2026
💡 Quick Summary
Price Band₹100 – ₹106
Upper Price₹106 / share
Lot Size1,200 shares
Min. Investment (Retail)₹2,54,400 (2 Lots)
Issue Size₹26.50 Cr
ListingBSE SME
🏦 Registrar & Lead Manager
Registrar
Kfin Technologies Ltd.
📞 040-79615565
[email protected]
Lead Manager
Nirbhay Capital Services Pvt.Ltd.
📍 Registered Address
Himalaya Nutravedics India Ltd.
Plot No. 101/A, Phase-III, Industrial Development Park,
Cherlapally, Hindustan Cables Ltd, Uppal,
Hyderabad, Telangana — 500051
📞 +91-9063498493
[email protected]
🛡️ Regulatory Note: SME IPO investments are subject to SEBI regulations and higher lot size restrictions. Always read the Prospectus/DRHP before applying. Consult a SEBI-registered advisor before investing.
⚠️ Disclaimer: This page presents publicly available information from the Himalaya Nutravedics IPO DRHP for informational purposes only. This format is generated adhering to the required structure as specified in the IPO NEW FORMAT source file. It does not constitute investment advice. IPO investments are subject to market risk. Please read all offer documents and consult a SEBI-registered advisor before investing.
📊
Track Himalaya Nutravedics India IPO 2026: Price Band, GMP, Dates, Lot Size, Allotment & Listing Details GMP
Check real-time grey market premium, daily GMP history & estimated listing price.
Check GMP →

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top